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Elongation factor 2 (EF-2), ADP-ribosylated in vitro by the A-fragment of diphtheria toxin, can (in the presence of GMPPCP) form stable com- 
plexes with ribosomes regardless of whether the ribosomes are empty or carrying poly(IJ) and Phe-tRNA in the A-site. Despite its efficient binding 
to ribosomes, ADP-ribosyl-EF-2, in contrast to the non-modified EF-2 is unable to promote the shift of Phe-tRNA from the A-site to the P-site 
of the ribosome as determined by the puromycin reaction, i.e. it is incapable of promoting the translocation reaction within the ribosome. 
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1. INTRODUCTION 
Protein biosynthesis at the elongation stage in 
eukaryotes is mediated by two elongation factors, EF-1 
and EF-2. EF-1 is responsible for codon-dependent bin- 
ding of aminoacyl-tRNA to the A-site of the ribosome. 
EF-2 promotes the translocation of peptidyl-tRNA 
from the A-site to the P-site, coupled with the displace- 
ment of deacylated tRNA and the mRNA shift by one 
codon (reviewed in [l]). 
EF-2 can be ADP-ribosylated in the reaction with 
NAD+, catalyzed by the A-fragment of diphtheria tox- 
in [2,3]. ADP-ribosylation occurs at a unique 
aminoacyl residue - diphthamide [4] - and results in 
inactivation of the factor and complete inhibition of 
protein synthesis [2,3,5]. 
Promotion of translocation includes several EF-2 
partial reactions: pretranslocation binding of the 
EF-2/GTP complex to a ribosome, translocation reac- 
tion itself, ribosome- and EF-Zdependent hydrolysis of 
GTP to GDP and inorganic phosphate, dissociation of 
the EF-2/GDP complex and the exchange of GDP 
bound to EF-2 to GTP (see review [l]). It is of interest 
to know which of the enumerated partial reactions of 
EF-2 is actually blocked by ADP-ribosylation. 
Previous reports in the literature did not clarify this 
problem, only negative or contradictory results were 
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obtained [a-12]. In one of the first reviews [6] devoted 
to this problem it was summarized that all the partial 
functions of EF-2 studied do not seem to be affected by 
ADP-ribosylation. It was even reported that ADP- 
ribosyl-EF-2 is able to promote a single translocation 
act [7]. The mechanism by which ADP-ribosylation in- 
hibits EF-2 functioning was called ‘a mystery’ [6]. 
Later it was reported that ADP-ribosylation partially 
[ 111, or even completely [ 121, inhibits pretranslocation 
binding of EF-2 to ribosomes. However, these results 
contradict a number of earlier studies [&lo]. 
In this paper we present a study on the effect of 
ADP-ribosylation at two consecutive steps of EF-2 
functioning: the binding of the factor to ribosomes 
(empty or carrying poly(U) and Phe-tRNA) and the 
shift of Phe-tRNA from the A-site to the P-site of the 
ribosome as tested by puromycin reactivity. From the 
data obtained we conclude that ADP-ribosylation 
makes EF-2 inactive to promote translocation without 
affecting its ability to bind to ribosomes. 
2. MATERIALS AND METHODS 
EF-1 and EF-2 were obtained from a rabbit reticulocyte ribosome- 
free extract as reported previously [13]. 
ADP-ribosylation of EF-2 was done as in [14], with minor 
modifications. The EF-2 preparation (260 fig, 200 ~1) was incubated 
for 10 mm at 37°C with 10 nmol of non-radioactive NAD’ (Boehr- 
inger) or nicotinamide-[lJ-14C]adenine dinucleotide ([14C]NAD+, 
260 mCi/mmol, Amersham) and 10 fig of diphtheria toxin 
(Calbiochem). 
40 S and 60 S ribosomal subunits were isolated from rabbit 
reticulocytes as in [15]. 
Ribosomes carrying poly(U) and [3H]Phe-tRNA in the A-site (A- 
ribosome) were prepared in the presence of EF-1 and GTP as in [13]. 
The translocation reaction was performed as follows. The incubation 
mixture (50 ~1) contained 3.5 pmol of A-ribosome, 0.2 mM of GTP 
or GMPPCP and varying amounts of EF-2 or ADP-ribosyl-EF-2 in 
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40 mM Tris-HCl, pH 7.6, 100 mM KCl, 10 mM M&12 and 2 mM 
dithiothreitol. After 15 min of incubation at 37°C puromycin was 
added and the amount of [3H]Phe-puromycin formed was determin- 
ed [13]. 
3. RESULTS AND DISCUSSION 
3.1. ADP-ribosylation does not affect pretranslocation 
binding of EF-2 to ribosomes 
As mentioned above, the data concerning the effect 
of ADP-ribosylation on pretranslocation binding of 
EF-2 to ribosomes are contradictory [8-121. Here we 
reinvestigated this effect. 
Pretranslocation binding of EF-2 to ribosomes can 
be studied in a model system with empty ribosomes 
(reassociated from ribosomal subunits) in the presence 
of GMPPCP, a non-hydrolyzable analog of GTP. 
Ribosomal subunits were mixed with ADP-ribosylated 
or native EF-2 and various guanyl nucleotides under 
conditions of reassociation of ribosomes and specific 
complex formation with EF-2. Complexes of EF-2 with 
ribosomes were detected by sucrose gradient cen- 
trifugation. 
As shown in fig.lC, ADP-ribosyl-EF-2 as well as the 
native factor (fig.lA) formed stable complexes with 
empty ribosomes in the presence of GMPPCP. Accor- 
ding to our calculations in both cases these complexes 
are rather stoichiometric. No complexes were detected 
when there were no nucleotides (fig. 1, panel B and D) 
or with GTP or GDP in the reaction mixtures (data not 
shown). These data are in good agreement with the 
results in [8, lo] but contradict the data in [11,12]. 
An experiment on the competition of ADP-ribosyl- 
EF-2 and native EF-2 for binding to a limited amount 
of ribosomes in the presence of GMPPCP showed that 
the share of ADP-ribosyl-EF-2 in the fraction of the 
ribosome-bound factor is the same as that in the initial 
mixture (table 1). Thus, even under conditions of com- 
petition no difference in the affinity of ADP-ribosyl- 
EF-2 or EF-2 for empty ribosomes is observed. 
In the process of peptide elongation EF-2 does not 
bind to empty, but to translating ribosomes with 
mRNA, peptidyl-tRNA in the A-site and deacylated 
tRNA in the P-site. To simulate this situation we 
prepared ribosomes, not less than 80% of which carried 
poly(U) and t3H]Phe-tRNA in the A-site (A- 
ribosomes). A comparison of binding of ADP-ribosyl- 
EF-2 and native EF-2 to A-ribosomes in the presence of 
GMPPCP or GDP did not reveal any dissimilarity of 
the two forms of the factor (fig.2). Both forms of EF-2 
bind to A-ribosomes in the presence of GMPPCP and 
practically no complexes are detected when GDP is 
added to the reaction mixture (fig.2). 
3.2. Effect of EF-2 ADP-ribosylation on Phe-tl2NA 
translocation from the A-site to the P-site of the 
ribosome 
As early as 1976 it was shown that ADP-ribosyl-EF-2 
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Fig.1. Effect of EF-2 ADP-ribosylation on its binding to empty 
reconstituted ribosomes. 20 pmol of ribosomes (equimolar mixture 
of 40 S and 60 S ribosomal subunits) were mixed with 50 pmol of 
EF-2 (A,B) or 50 pmol of [r4C]ADP-ribosyl-EF-2 (C,D) in 200 ~1 of 
30 mM Tris-HCl, pH 7.6, 80 mM KCl, 1 mM MgCla, 2 mM 
dithiothreitol and 0.2 mM GMPPCP (A,C) or without GMPPCP 
(B,D). After incubation for 5 min at 37°C the mixture was applied 
to a 15-33.5% exponential sucrose gradient prepared in the same 
solution (without GMPPCP) and centrifuged for 3 h in a SW-41 
rotor at 40000 rpm at 4°C. After centrifugation, the gradients were 
fractionated. EF-2 was detected by TCA-precipitated radioactive 
material either directly (C,D) or after incubation with diphtheria 
toxin and [%]NAD+ in the presence of 1 mM EDTA (A,B). (---) 
Absorbance at 260 nm; (O- - 4) radioactivity. 
at a high concentration in the presence of GTP is able 
to promote at least a single translocation act [7]. 
However, the authors [7] failed to obtain this effect 
when GTP in the reaction mixture was substituted by 
GMPPCP. It is well-known now that EF-2, taken in 
substrate amounts, can promote the translocation act 
also in the presence of non-hydrolyzable analogs of 
Table 1 
Competition of ADP-ribosyl-EF-2 and EF-2 for binding to empty 
ribosomes in the presence of GMPPCP 
Factor Cont. 
(pmol) 
Additions [r4C]ADP- 
ribosyl-EF-2 
bound (umol) 
[‘4C]ADP-ribosyl-EF-2 50 0.2 mM GMPPCP 15.3 
none 0.8 
EF-2 
I 
25 
t 
0.2 mM GMPPCP 7.8 
[r4C]ADP-ribosyl-EF-2 25 none 1.1 
200~1 of the reaction mixture contained 16 pmol of ribosomes 
(equimolar mixture of 40 S and 60 S ribosomal subunits) in 30 mM 
Tris-HCl buffer, pH 7.6, 80 mM KCl, 6 mM MgC12, 2 mM 
dithiothreitol and other additions, as shown in the table. After 5 min 
incubation at 37°C the mixture was centrifuged through 3 ml of 10% 
sucrose, prepared in the same buffer for 2 h in a Type 75 rotor at 
45000 rpm at 4°C. Radioactivity of [r4C]ADP-ribosyl-EF-2 was 
measured in ribosomal pellets. An equimolar mixture of EF-2 and 
[r4C]ADP-ribosyl-EF-2 was prepared by incubation of EF-2 with 
diphtheria toxin in a molar ratio of EF-2 to [r4C]NAD+ 1:0.6 
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Fig.2. Effect of EF-2 ADF-ribosylation on its binding to A- 
ribosomes. 7 pmol of A-ribosomes were mixed with 16 pm01 of EF-2 
(1 and 2) or 16 pmol of ADP-ribosyl-EF-2 (3 and 4) in 100 ~120 mM 
Tris-HCl buffer, pH 7.6, 100 mM KCl, 10 mM MgCl2, 2 mM 
dithiothreitol and 0.2 mM GDP (1,3) or 0.2 mM GMPPCP (2,4). 
After 5 min incubation at 37°C the reaction mixtures were 
centrifuged for 2 h in Type 7.5 Beckman rotor at 45000 rpm at 4°C 
through 3 ml of 10% sucrose, prepared in the same buffer, but 
without nucleotides. The results of SDS-electrophor~is of pellets are 
presented. 
GTP [ 16,171. In the light of these data, translocation at 
high concentration of ADP-ribosyl-EF-2 in the 
presence of GTP, but not GMPPCP 171, can be ex- 
plained by an admixture of the non-modified factor, 
working catalytically with GTP. 
Here we reinvestigated this problem and studied the 
ability of ADP-ribosyl-EF-2 to promote translocation 
of Phe-tRNA from the A-site (puromycin non-reactive) 
to the F-site ~uromycin reactive) of the ribosome in 
the presence of GTP or GMPPCP and tested it by the 
puromycin reaction. In our experiments ADP-ribosyl- 
EF-2 in contrast to the native factor was unable to pro- 
mote transition of [14C]Phe-tRNA to the puromycin 
reactive state in the presence of GTP or GMPPCP even 
when ADP-ribosyl-EF-2 was added in a large excess 
(table 2) or when the time of translocation reaction was 
prolonged from 15 min up to 2 h (data not shown; 
Neither diphtheria toxin nor NAD+ when added to the 
reaction mixture separately affect the activity of EF-2 
(data not shown). 
In this study we have demonstrate that ADP- 
ribosyl-EF-2 can bind to pretranslocated ribosomes and 
that such a binding does not result in the translocation 
reaction. One of the explanations of this fact is damage 
Table 2 
Effect of EF-2 ADP-ribosylation on translocation of [3H]Phe-tRNA 
Factor Cont. 
(pmol) 
Nucleotide Yield of [“HIPhe 
puromycin (pmol) 
None 
None 
EF-2 8 
80 
8 
ADP-ribosyl-EF-2 8 
80 
1 
8 
GMPPCP 0.10 
GTP 0.14 
GMPPCP 2.34 
GMPPCP 2.66 
GTP 3.02 
GTP 3.10 
GMPPCP 0.23 
GMPPCP 0.31 
GTP 0.20 
GTP 0.32 
of the EF-2 active center which catalyzes translocation 
within the ribosome. Another possibility can be that 
pre-translocation binding of ADP-ribosyl-EF-2 to the 
ribosome proceeds in an incorrect manner. 
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